Client Success

Alnylam

Utilizing AI in Conjunction with RWD to Discover Undiagnosed Patients Suffering From a Rare Disease

Hereditary ATTR amyloidosis (hATTR) is a progressive condition caused by a mutation or error in the TTR (transthyretin) gene...

Audentes

Shortening the Diagnostic Journey of a Life-Threatening Rare Disease with Evolutionary Computation

X-Linked Myotubular Myopathy (XLMTM), is a rare and life-threatening neuromuscular disease that is characterized by...

Biogen

Utilizing Artificial Intelligence in Conjunction with Real World Data to Optimize Clinical Trial Recruitment

In the midst of conducting a clinical trial, Biogen had to confront that very few target enrollees were actually trial-eligible…

Insmed

Utilizing AI in Conjunction with RWD to Uncover the Patient Diagnostic and Treatment Journey

Nontuberculous Mycobacterial Lung Diseases (NTM) is a progressive and chronic condition that causes severe... 

Momenta

The Identification of a Rare Disease Patient Population Using Predictive Analytics of a Clinical Cohort

Warm autoimmune hemolytic anemia (wAIHA) is an autoimmune disorder characterized by the premature destruction...

X4 Pharmacueticals

Utilizing AI and RWD to Assess the Market for a Therapy to Combat a Rare Disease

WHIM Syndrome is a rare immuno-deficiency caused by gain-of-functions mutations in the C-X-C chemokine...

Want to Know More?

Learn how IPM.ai transforms real world data into real world insights that uncover the ideal patient and their healthcare ecosystem so pharmaceutical companies can accelerate the successful research, development and commercialization of life-savings therapies.

Let's Talk